These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33275300)

  • 1. A survey of primary care practitioners' referral habits and recommendations of allergen-specific immunotherapy for canine and feline patients with atopic dermatitis.
    Flanagan S; Schick A; Lewis TP; Chu Tater K; Rishniw M
    Vet Dermatol; 2021 Apr; 32(2):106-e21. PubMed ID: 33275300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to identify perceived barrier and motivating factors of primary veterinarians in the USA for specialty referral and management of atopic dermatitis with allergen-specific immunotherapy.
    Flanagan S; Schick A; Lewis TP
    Vet Dermatol; 2020 Oct; 31(5):371-e98. PubMed ID: 32416025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.
    Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F
    Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats.
    Trimmer AM; Griffin CE; Boord MJ; Rosenkrantz WS
    Vet Dermatol; 2005 Oct; 16(5):324-9. PubMed ID: 16238812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor?
    Ramió-Lluch L; Brazís P; Ferrer L; Puigdemont A
    Vet Rec; 2020 Dec; 187(12):493. PubMed ID: 33082241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
    Griffin CE; Hillier A
    Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-specific immunotherapy prescription patterns in veterinary practice: a US population-based cohort study.
    Tater KC; Cole WE; Pion PD
    Vet Dermatol; 2017 Aug; 28(4):362-e82. PubMed ID: 28164402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline immunotherapy.
    Trimmer AM; Griffin CE; Rosenkrantz WS
    Clin Tech Small Anim Pract; 2006 Aug; 21(3):157-61. PubMed ID: 16933483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Allergen Immunotherapy.
    Mueller RS
    Vet Clin North Am Small Anim Pract; 2019 Jan; 49(1):1-7. PubMed ID: 30227970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of allergen immunotherapy, a successful therapy for canine atopic dermatitis and feline atopic skin syndrome.
    Mueller RS
    J Am Vet Med Assoc; 2023 Jun; 261(S1):S30-S35. PubMed ID: 36940185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
    Plant JD; Neradilek MB
    BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy.
    Martini F; Rostaher A; Favrot C; Fischer N
    Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
    Kawano K; Mizuno T
    Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
    Mueller RS; Veir J; Fieseler KV; Dow SW
    Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy.
    Colombo S; Hill PB; Shaw DJ; Thoday KL
    Vet Rec; 2007 Jun; 160(25):861-4. PubMed ID: 17586789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of immunotherapy for canine atopic dermatitis: a review.
    DeBoer DJ
    Vet Dermatol; 2017 Feb; 28(1):25-e6. PubMed ID: 28133873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of immunological responses to allergen-specific immunotherapy in horses with IgE associated dermatological disease, a pilot study.
    Radwanski NE; Morris DO; Boston RC; Cerundolo R; Lee KW
    Vet Dermatol; 2019 Jun; 30(3):255-e78. PubMed ID: 30828914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
    Fischer NM; Rostaher A; Favrot C
    Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
    Mueller RS; Bettenay SV
    Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.